These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2509505)

  • 21. Growth hormone, insulin-like growth factor and the kidney.
    Krieg RJ; Santos F; Chan JC
    Kidney Int; 1995 Aug; 48(2):321-36. PubMed ID: 7564099
    [No Abstract]   [Full Text] [Related]  

  • 22. Disorders of somatic growth.
    Bonati B; Cacciari E; Canossi GC; Cheli E; Della Casa L; Giordano G; Marotti G; Marrama P; Morabito F; Nicoletti I
    Panminerva Med; 1982; 24(4):269-74. PubMed ID: 7170111
    [No Abstract]   [Full Text] [Related]  

  • 23. Can growth hormone counteract the catabolic effects of steroids?
    Mauras N
    Horm Res; 2009 Nov; 72 Suppl 1():48-54. PubMed ID: 19940496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human growth hormone. A symposium.
    Maclaren NK; CORNBLATH M; Raiti S
    Am J Dis Child; 1974 Jun; 127(6):906-8. PubMed ID: 4600622
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth failure in cystic fibrosis: a true need for anabolic agents?
    Colombo C; Battezzati A
    J Pediatr; 2005 Mar; 146(3):303-5. PubMed ID: 15756206
    [No Abstract]   [Full Text] [Related]  

  • 26. Assays for insulin-like growth factors and their binding proteins: practicalities and pitfalls.
    Rosenfeld RG; Gargosky SE
    J Pediatr; 1996 May; 128(5 Pt 2):S52-7. PubMed ID: 8627471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The growth hormone/somatomedin C system from the first years of life to young adulthood. Physiological aspects and physiopathologic involvement in diabetic syndrome].
    Bertoldi C; Riva P; Bonati ME
    Minerva Endocrinol; 1989; 14(4):233-49. PubMed ID: 2576885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone, growth factors and diabetes mellitus].
    Orskov H; Hansen AA; Christensen SE; Christiansen JS; Schmitz O; Lundbaek K; Flyvbjerg A
    Journ Annu Diabetol Hotel Dieu; 1987; ():79-89. PubMed ID: 3302497
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth hormone and insulin-like growth factor I: nutritional pathophysiology and therapeutic potential.
    Bier DM
    Acta Paediatr Scand Suppl; 1991; 374():119-28. PubMed ID: 1957615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone.
    Schaff-Blass E; Burstein S; Rosenfield RL
    J Pediatr; 1984 Jun; 104(6):801-13. PubMed ID: 6427436
    [No Abstract]   [Full Text] [Related]  

  • 32. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
    Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
    Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth hormone. I. Physiological and biochemical considerations].
    Campino C; Pumarino H
    Rev Med Chil; 1982 Jan; 110(1):43-52. PubMed ID: 6130589
    [No Abstract]   [Full Text] [Related]  

  • 34. Physiology of the somatotropic axis with particular reference to the ruminant.
    Gluckman PD; Breier BH; Davis SR
    J Dairy Sci; 1987 Feb; 70(2):442-66. PubMed ID: 3553258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGFs/somatomedins: significance for growth.
    Froesch ER; Zapf J
    Prog Clin Biol Res; 1985; 200():75-89. PubMed ID: 3909166
    [No Abstract]   [Full Text] [Related]  

  • 36. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
    Tönshoff B; Schaefer F; Mehls O
    Pediatr Nephrol; 1990 Nov; 4(6):654-62. PubMed ID: 2088470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal regulation of human growth.
    Rechler MM; Nissley SP; Roth J
    N Engl J Med; 1987 Apr; 316(15):941-3. PubMed ID: 3821841
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of mesangial cells in glomerulosclerosis.
    Striker LJ; Doi T; Conti F; Striker GE
    J Diabet Complications; 1991; 5(2-3):60-1. PubMed ID: 1663117
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone and diabetes in man. Old concepts--new implications.
    Luft R; Guillemin R
    Diabetes; 1974 Sep; 23(9):783-7. PubMed ID: 4606596
    [No Abstract]   [Full Text] [Related]  

  • 40. Off-label use of recombinant igf-I to promote growth: is it appropriate?
    Rosenbloom AL; Rivkees SA
    J Clin Endocrinol Metab; 2010 Feb; 95(2):505-8. PubMed ID: 20133470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.